Integrated Bioinformatics Analysis Suite for deep, targeted amplicon sequencing
Integrated Bioinformatics Analysis Suite for deep, targeted amplicon sequencing
批准号:
8315541
负责人:
Brian Clifton Haynes
金额:
$24.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-25 至 2014-08-31
关键词:
AddressAlgorithmsAmendmentBioinformaticsBiological MarkersCell LineClinicalClinical ResearchComputer softwareControlled StudyCopy Number PolymorphismDataData AnalysesDetectionDevelopmentDiagnosticDideoxy Chain Termination DNA SequencingEscherichia coliEvaluationFine needle aspiration biopsyGene MutationGenerationsGenetic VariationGenetic screening methodGenomeGenomicsGoalsIonsLaboratoriesLifeLightMalignant NeoplasmsMethodsModelingMutationNucleotidesOligonucleotidesOutcomePharmacogenomicsPharmacologic SubstancePhasePositioning AttributePreparationProcessReadingSamplingScreening procedureSemiconductorsServicesSingle Nucleotide PolymorphismSoftware ToolsSourceSpecificitySpecimenSystemTechnologyTestingThyroid GlandTimeTitrationsValidationVariantWorkbasecancer typecomputerized data processingcostdesigndrug discoveryimprovedinsertion/deletion mutationinstrumentinstrumentationnext generationresearch clinical testingtool
中文摘要
描述(由申请人提供):本提案的目的是开发一种生物信息学管道或集成生物信息学分析套件(IBAS),专门用于新型Ion Torrent个人基因组机器(PGM)上的超深度靶向扩增子测序。这将提高变异检测的准确性,并能够分析不同类型癌症的遗传变异。PGM中使用的技术基于半导体技术的非光学检测,因此具有足够的独特性,可在其他技术用于初始测序时用作验证性检测的正交平台。与下一代测序的其他方法相比,PGM提供了显著的优势,使样品制备到数据生成的过程能够在一天内完成。然而,它受到技术的固有限制,主要是32端的错误。另外,目前可用的SNP识别器不是特别适合于高通量、超定量分析。
深度扩增子测序,并且很少有算法可用于检测其他类型的基因组变异。拟议的管道旨在解决这些问题,并满足对PGM中采用的小组设计的扩增子测序技术进行优化的生物信息学的迫切需求。为了实现所提出的目标,1)将构建IBAS,其结合不同的方法来读取预处理、与参考序列的比对和误差建模,以使得能够检测单核苷酸多态性(SNPS)、插入/缺失(indel)、拷贝数变异(CNV)和其他结构变异;和2)将进行变异来源的综合评价,并优化IBAS用于扩增子测序。然后将通过处理来自PGM的数据来验证优化的管道,以用于对临床甲状腺细针抽吸活检中检测到的突变进行正交验证。成功的结果将使Asuragen能够为临床研究和诊断提供高通量超深度测序服务。
公共卫生相关性:我们的目标是开发一种生物信息学应用程序,专门用于最近推出的Ion Torrent Personal Genome Machine(PGM)中采用的技术,该技术将提高检测不同类型癌症中遗传变异的准确性。PGM是一种紧凑的台式下一代测序仪器,能够快速测序整个基因组,并且成本比现有系统低得多。Asuragen将使用该应用程序为临床研究和诊断提供高通量测序服务。
英文摘要
DESCRIPTION (provided by applicant): The aim of this proposal is to develop a bioinformatics pipeline, or Integrated Bioinformatics Analysis Suite (IBAS), specific for ultra-deep, targeted amplicon sequencing on the new Ion Torrent Personal Genome Machine (PGM). This will improve the accuracy of variation detection and enable analysis of genetic variations in different types of cancer. The technology used in the PGM is based on non-optical detection with semiconductor technology and so is sufficiently unique to enable its use as an orthogonal platform for confirmatory testing when other technologies are used for initial sequencing. The PGM offers a significant advantage over other methods of next generation sequencing by enabling the process of sample preparation to data generation to be completed in one day. However, it suffers from the inherent limitations of the technology, mainly errors at the 32 end. Additionally, currently available SNP callers are not particularly suited to high-throughput, ultra
deep amplicon sequencing and there are few algorithms available for detecting other types of genomic variations. The proposed pipeline aims to address these issues and fill the urgent need for bioinformatics optimized for the panel-designed amplicon sequencing technology employed in the PGM. To achieve the proposed aims, 1) an IBAS that incorporates different approaches to read preprocessing, alignment to reference sequences, and error modeling to enable detection of single nucleotide polymorphisms (SNPS), insertion/deletions (indels), copy number variation (CNV) and other structural variation will be constructed; and 2) a comprehensive evaluation of the sources of variation will be performed, and the IBAS optimized for amplicon sequencing. The optimized pipeline will then be validated by processing data from the PGM for orthogonal validation of mutations detected in clinical thyroid fine needle aspiration biopsies. Successful outcome will enable Asuragen to provide a high-throughput ultra-deep sequencing service for clinical research and diagnostics.
PUBLIC HEALTH RELEVANCE: We aim to develop a bioinformatics application specific for the technology employed in the recently launched Ion Torrent Personal Genome Machine (PGM) that will improve the accuracy of detecting genetic variations in different types of cancer. The PGM is a compact, bench-top next generation sequencing instrument that enables rapid sequencing of an entire genome and at a much lower cost than established systems. The application will be used by Asuragen to offer a high-throughput sequencing service for clinical research and diagnostics.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s12920-014-0062-0
发表时间:
2014-11-14
期刊:
BMC medical genomics
影响因子:
2.7
作者:
[Choudhary A, Mambo E, Sanford T, Boedigheimer M, Twomey B, Califano J, Hadd A, Oliner KS, Beaudenon S, Latham GJ, Adai AT]
通讯作者:
Adai AT
Comprehensive Solution for Transcriptome Profiling of Archived Tissues
-
批准号:8758248
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Brian Clifton Haynes
-
依托单位:
Integrated Bioinformatics Analysis Suite for targeted NGS of clinical specimens
-
批准号:8715650
-
项目类别:
-
资助金额:$87.61万
-
财政年份:2012
-
负责人:Brian Clifton Haynes
-
依托单位:
海外基金